Thyroxine enhances breast cancer cell survival and proliferation via TRβ1-Dependent PI3K/AKT signaling.

Cano RY, Gómez SE, Ferrando EM, Redondo A, Zyla L, Bruna F, Pistone Creydt V, López Fontana C, Carón RW

Open source

DOI
10.1016/j.mce.2026.112915
Published
2026 Sep 7
Container
Molecular and cellular endocrinology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.mce.2026.112915,
  title = {Thyroxine enhances breast cancer cell survival and proliferation via TRβ1-Dependent PI3K/AKT signaling.},
  author = {Cano RY and Gómez SE and Ferrando EM and Redondo A and Zyla L and Bruna F and Pistone Creydt V and López Fontana C and Carón RW},
  year = {2026},
  journal = {Molecular and cellular endocrinology},
  doi = {10.1016/j.mce.2026.112915},
  url = {https://doi.org/10.1016/j.mce.2026.112915}
}

RIS

TY  - JOUR
TI  - Thyroxine enhances breast cancer cell survival and proliferation via TRβ1-Dependent PI3K/AKT signaling.
AU  - Cano RY
AU  - Gómez SE
AU  - Ferrando EM
AU  - Redondo A
AU  - Zyla L
AU  - Bruna F
AU  - Pistone Creydt V
AU  - López Fontana C
AU  - Carón RW
PY  - 2026
JO  - Molecular and cellular endocrinology
DO  - 10.1016/j.mce.2026.112915
UR  - https://doi.org/10.1016/j.mce.2026.112915
ER  - 

APA

RY, C., SE, G., EM, F., A, R., L, Z., F, B., V, P. C., C, L. F., & RW, C. (2026). Thyroxine enhances breast cancer cell survival and proliferation via TRβ1-Dependent PI3K/AKT signaling.. Molecular and cellular endocrinology. https://doi.org/10.1016/j.mce.2026.112915

Source records